393 search results for “titel development” in the Student website
-
Tommie LambregtsFaculty of Social and Behavioural Sciences
-
Alice BisschopFaculty of Social and Behavioural Sciences
-
Sissy HofmeesterFaculty of Social and Behavioural Sciences
-
Marit PauwelsFaculty of Social and Behavioural Sciences
-
Louise van GentFaculty of Social and Behavioural Sciences
-
Mariska Moreu-de JongFaculty of Social and Behavioural Sciences
-
Belia SchuurmanFaculty of Social and Behavioural Sciences
-
Sarah Smith -
Jolie FraiquinFaculty of Social and Behavioural Sciences
-
José DoumaFaculty of Social and Behavioural Sciences
-
Leiden students develop highly contagious card game
Infecting each other with viruses and bacteria while protecting yourself with medicines and vaccinations. Sounds like a fun evening, right? Master students Life Science & Technology Rafael Jezior and Dennis de Beeld certainly think so. Together, they developed ImmunoWars: an exciting card game based…
-
Gerard Persoon
Faculty of Social and Behavioural Sciences
-
Francesca Sofia SelanoFaculty of Social and Behavioural Sciences
-
Abhimanyu ChettriFaculty of Social and Behavioural Sciences
-
Ratna Saptari Soetikno Slamet
Faculty of Social and Behavioural Sciences
-
Marianne Maeckelbergh
Faculty of Social and Behavioural Sciences
-
Jan JansenFaculty of Social and Behavioural Sciences
-
Esther van de CampFaculty of Social and Behavioural Sciences
-
Ton DietzAfrika-Studiecentrum
-
Mark WestmorelandFaculty of Social and Behavioural Sciences
-
Thinley DemaFaculty of Social and Behavioural Sciences
-
Weiyan LowFaculty of Social and Behavioural Sciences
-
Benjamin Fogarty-ValenzuelaFaculty of Social and Behavioural Sciences
-
Xu LiuICLON
-
John BoyFaculty of Social and Behavioural Sciences
-
Leiden-developed drug candidate ready for final clinical trial phase
Bringing your drug candidates to patients is what many academic chemists dream about, but the road to this goal is long and bumpy. Now, Leiden small molecule nizubaglustat is ready for phase 3 clinical trials. This is thanks to a €132 million funding secured by the biotech spin-out Azafaros.
-
LACDR launches training programme for innovative drug development
The Leiden Academic Centre for Drug Research (LACDR) has received a €750,000 grant from ZonMw for QPharmNL. This is a continuing education programme that trains professionals in computational techniques in pharmacology for innovative drug development.
-
PhD candidate develops new device for diagnosing erectile dysfunction
Erection problems can have a huge impact on quality of life and health, but current diagnostic methods are painful, uncomfortable and technologically outdated. PhD candidate Evelien Trip has developed a new device that can measure erections more comfortably and painlessly.
-
Erwin Muller appointed Vice-Rector of Organisational Development
Leiden University’s Executive Board has appointed Erwin Muller as Vice Rector of Organisational Development. In this role, he will help further professionalise and improve the university’s organisation as per the Strategic Plan.
-
Katy LipsICLON
-
Wendy Schoneveld-TijstermanICLON
-
Emiel van der HartICLON
-
Hiske Heemskerk-BavelaarICLON
-
Sophia van Ghesel GrotheFaculty of Social and Behavioural Sciences
-
Floris VelemaICLON
-
Birgitta de GraafICLON
-
Evelien StoutjesdijkICLON
-
Hubertus Irth -
Özlem ShawICLON
-
Sanne BoskerICLON
-
Teun van Gelder -
Elena Neri -
Nina AdriaanseFaculty of Social and Behavioural Sciences
-
Myfel PalugaFaculty of Social and Behavioural Sciences
-
Anna Anna LotzFaculty of Social and Behavioural Sciences
-
Thijs Jan van Schie
Faculty of Social and Behavioural Sciences
-
Sita ter HaarFaculty of Social and Behavioural Sciences
-
Etienne BourelFaculty of Social and Behavioural Sciences
-
Diana MachielseICLON
-
Leiden students develop AI tool for marking assignments
Jeroen van Gessel’s lecturers didn’t always have time for extensive feedback on his written assignments. So, together with tech-savvy friend Menno Hahury, he founded Eduface, a startup to develop an AI teaching assistant. ‘The first users now work three times faster.'